Olanzapine Dosing by Weight
Olanzapine is not routinely dosed by body weight in clinical practice; instead, it is dosed by fixed milligram amounts based on indication, age, and clinical response.
Standard Dosing Recommendations
Adults
According to FDA labeling and clinical guidelines, olanzapine dosing in adults follows fixed-dose regimens 1:
- Initial dose: 2.5-5 mg per day at bedtime
- Typical therapeutic range: 5-20 mg per day
- Maximum dose: 10 mg per day (for most indications), though doses up to 40 mg/day have been studied 2
The 2002 American Family Physician guidelines specifically recommend starting at 2.5 mg per day at bedtime with a maximum of 10 mg per day, usually divided into twice-daily dosing 2.
Adolescents (13 years and older)
The FDA label explicitly states that safety and efficacy have not been established in patients under 13 years of age 1. For adolescents 13 and older, dosing follows similar fixed-dose principles as adults, starting low and titrating based on response.
Weight-Based Dosing Context
While olanzapine is not prescribed using weight-based calculations, research provides some context:
- A pharmacokinetic study examined doses ranging from 0.05-0.6 mg/kg body weight in adults with schizophrenia 3
- This translates to approximately 3.5-42 mg for a 70 kg adult, which encompasses the clinical dosing range
Key Clinical Considerations
Important caveats:
Weight gain is a major concern: Olanzapine causes significant weight gain, with adolescents experiencing greater increases than adults (mean 11.2 kg over 24 weeks in adolescents vs. 5.6 kg over 48 weeks in adults) 1
Metabolic monitoring is essential: Regular monitoring of weight, glucose, and lipids is required regardless of dose 1
Dose-response relationship exists: Higher doses (40 mg/day) produced more weight gain than lower doses (10 mg/day) in controlled trials 1
Practical Dosing Algorithm
- Start low: Begin with 2.5-5 mg daily at bedtime
- Titrate gradually: Increase by 2.5-5 mg increments every 3-7 days based on clinical response and tolerability
- Target therapeutic dose: Most patients respond to 5-20 mg daily
- Monitor closely: Assess for efficacy, sedation, metabolic effects, and extrapyramidal symptoms
- Adjust for special populations: Consider lower starting doses in elderly or medically compromised patients
The absence of weight-based dosing reflects olanzapine's pharmacology—therapeutic effects and side effects are driven by receptor occupancy rather than simple weight-proportional distribution 3.